These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 34975317)

  • 41. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
    Burchard PR; Ruffolo LI; Ullman NA; Dale BS; Dave YA; Hilty BK; Ye J; Georger M; Jewell R; Miller C; De Las Casas L; Jarolimek W; Perryman L; Byrne MM; Loria A; Marin C; Chávez Villa M; Yeh JJ; Belt BA; Linehan DC; Hernandez-Alejandro R
    Hepatol Commun; 2024 Aug; 8(8):. PubMed ID: 39101793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
    Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
    Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression.
    Jiang Y; Qiu Q; Jing X; Song Z; Zhang Y; Wang C; Liu K; Ye F; Ji X; Luo F; Zhao R
    Biochem Biophys Res Commun; 2023 Jan; 641():177-185. PubMed ID: 36535076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs.
    Qi R; Bai Y; Li K; Liu N; Xu Y; Dal E; Wang Y; Lin R; Wang H; Liu Z; Li X; Wang X; Shi B
    Drug Resist Updat; 2023 May; 68():100960. PubMed ID: 37003125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
    Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
    Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts.
    Yamanaka T; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Hagiwara K; Gantumur D; Handa T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Shirabe K
    Br J Cancer; 2020 Mar; 122(7):986-994. PubMed ID: 32015511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholangiocarcinoma cell line TK may be useful for the pharmacokinetic study of the chemotherapeutic agent gemcitabine.
    Kamada M; Akiyoshi K; Akiyama N; Funamizu N; Watanabe M; Fujioka K; Ikeda K; Manome Y
    Oncol Rep; 2014 Aug; 32(2):829-34. PubMed ID: 24891233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Wang Y; Yu H; Xie X; Deng T; Ye L; Wu L; Ding X; Yang Z; Zhu Q; Li J; Zheng Y; Yu Z; Chen G
    Oncogene; 2021 Jun; 40(25):4324-4337. PubMed ID: 34079085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
    Zhang HW; Shi Y; Liu JB; Wang HM; Wang PY; Wu ZJ; Li L; Gu LP; Cao PS; Wang GR; Ma YS; Fu D
    J Cell Mol Med; 2021 Apr; 25(8):3699-3713. PubMed ID: 33621425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis.
    Li BL; Lu W; Qu JJ; Ye L; Du GQ; Wan XP
    J Cell Physiol; 2019 Mar; 234(3):2943-2953. PubMed ID: 30146796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma.
    Yang Y; Cao X; Wang Y; Wu X; Zhou P; Miao L; Deng X
    Liver Int; 2024 Jul; 44(7):1651-1667. PubMed ID: 38554043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach.
    Ahn KS; O'Brien D; Kang YN; Mounajjed T; Kim YH; Kim TS; Kocher JA; Allotey LK; Borad MJ; Roberts LR; Kang KJ
    Hepatol Int; 2019 Jul; 13(4):490-500. PubMed ID: 31214875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice.
    Wabitsch S; Tandon M; Ruf B; Zhang Q; McCallen JD; McVey JC; Ma C; Green BL; Diggs LP; Heinrich B; Greten TF
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1166-1178. PubMed ID: 34033968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.
    Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):601-12. PubMed ID: 25708948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.